Dr. Nathenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
# Dana-Far
Boston, MA 02215Phone+1 617-582-9396
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2016
University of MarylandFellowship, Hematology and Medical Oncology, 2012 - 2015
UPMC Medical EducationResidency, Internal Medicine, 2009 - 2012
Tufts University School of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2016 - 2025
NH State Medical License 2024 - 2024
RI State Medical License 2020 - 2020
TX State Medical License 2015 - 2017
MD State Medical License 2012 - 2015
PA State Medical License 2009 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas Start of enrollment: 2019 May 13
Publications & Presentations
PubMed
- 1603 citationsEfficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W. Laetsch, Shivaani Kummar, Steven G. DuBois, Ulrik Lassen
The New England Journal of Medicine. 2018-02-21 - 51 citationsUterine Adenosarcoma: a ReviewMichael J. Nathenson, Vinod Ravi, Nicole D. Fleming, Wei Lien Wang, Anthony P. Conley
Current Oncology Reports. 2016-10-07 - 35 citationsImmunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone SarcomasMichael J. Nathenson, Anthony P. Conley, Edward A. Sausville
The Oncologist. 2018-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
